Senseonics Holdings, Inc.
- SENS
- NASDAQ
- Medical devices
- Continuous Glucose Monitoring (CGM)
$8.02
Today +3.15%Quote Oct 19, 2026, 08:00 PM UTC
−16.28%over the last month
Max drawdown −24.9%From 1-month high −22.4%3 months +59.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Senseonics
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa.
Sector
Healthcare
Industry
Medical devices
Exchange
NASDAQ
Employees
130
Founded
1996
Market value
$423.8M
Quote Oct 19
Floor
$7.64
4.7% below price
Resistance
$8.32
3.8% above price
Price vs analyst targets
17 analysts
Lowest target
$8.00Highest target
$18.00
$8.00Highest target
$18.00
- Price $8.02
- Average target $13.00
- Analysts' target range
The price is close to the lowest analyst target. Analysts' average target sits about 62% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about SENSPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free